Accumulation of a form of p27(Kip1) not associated with Cdk-cyclin complexes in transforming growth factor-β-arrested Mv1Lu cells

Experimental Cell Research

Volumn 259, Issue 1, 2000, Pages 107-116

  Taipale, Minna ^a   Tiihonen, Erja ^a   Heiskanen, Annamari ^a   Laiho, Marikki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cell cycle; Cyclin dependent kinase; G1 arrest; p27 cyclin dependent kinase inhibitor; TGF

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; MONOCLONAL ANTIBODY; PROTEIN P27; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CARCINOMA CELL; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; KERATINOCYTE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS EPITHELIUM; MELANOMA CELL; MINK; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

ANIMALIA; MUSTELA VISON;

EID: 0034714498     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4959     Document Type: Article

References (45)

1. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β
2. Inhibitors of the Cip/Kip family
3. 1-phase progression
4. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
5. Interleukin-2-mediated elimination of the p27(Kip1) cyclin-dependent kinase inhibitor prevented by rapamycin
6. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27(Kip1)) of cyclin-dependent kinase 4 activation
7. p27(Kip1), a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest
8. Cloning of p27(Kip1), a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
9. Regulation of cyclin E and p27(kip) during mitosis in BALB/c 3T3 cells
10. Requirement of p27(Kip1) for restriction point control of the fibroblast cell cycle
11. Translational control of p27(Kip1) accumulation during the cell cycle
12. Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest
13. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
14. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
15. 1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome
16. Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing
17. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2
18. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes
19. Cyclin E-CDK2 is a regulator of p27(Kip1)
20. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27(Kip1)
21. Crystal structure of the p27(Kip1) cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex
22. Redistribution of the CDK inhibitor p27 between different cyclin. CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation
23. Formation of p27-CDK complexes during the human mitotic cell cycle
24. The role of p27kip1 in the in vitro differentiation of murine keratinocytes
25. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) with cyclin A-Cdk2 and cyclin D2-Cdk4
26. New functional activities for the p21 family of CDK inhibitors
27. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
28. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation
29. p15(INK4B) is a potential effector of TGF-β-induced cell cycle arrest
30. Transforming growth factor-β stabilizes p15(INK4B) protein, increases p15(INK4B)-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells
31. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2
32. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism
33. 3 up-regulation of p27(Kip1) and p21(Cip1) by expression of RasN17 in epithelial cells
34. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15
35. Hepatocyte growth factor releases mink epithelial cells from transforming growth factor-β1 induced growth arrest by restoring Cdk6 expression and cyclin E-associated Cdk2-activity
36. D-type cyclin-dependent kinase activity in mammalian cells
37. Expression of the human retinoblastoma gene product in mouse fibroblasts: Effects on cell proliferation and susceptibility to transformation
38. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21(Cip1) and p27(Kip1) in anchorage-independent cells
39. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma
40. 1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-β
41. Cyclin D3-associated kinase activity is regulated by p27(kip1) in BALB/c 3T3 cells
42. 1 cyclins and cyclin-dependent protein kinases
43. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 And p16 bind to kinases, p21 and p27 bind to cyclins
44. 1 kinase activity for Cdk6, a novel cyclin D partner
45. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins